MDT
53
-4
O
37
-3
PYPL
47
2
MPC
41
5
AVB
67
-3
T
60
-3
BXP
63
-4
PPL
67
-2
MSFT
57
2
THC
58
-4
FAST
48
2
BSX
69
-2
IR
71
8
DNB
54
-4
HST
52
3
BAC
41
5
WM
62
-6
FOXA
41
4
INTC
41
4
VRTX
60
-3
MDT
53
-4
O
37
-3
PYPL
47
2
MPC
41
5
AVB
67
-3
T
60
-3
BXP
63
-4
PPL
67
-2
MSFT
57
2
THC
58
-4
FAST
48
2
BSX
69
-2
IR
71
8
DNB
54
-4
HST
52
3
BAC
41
5
WM
62
-6
FOXA
41
4
INTC
41
4
VRTX
60
-3
Financhill
Back

The Carlyle Group 10K Form

Buy
63

CG
The Carlyle Group

Last Price:
42.31
Seasonality Move:
0.34%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CG News And Ratings

See the #1 stock for the next 7 days that we like better than CG

CG Financial Statistics

Sales & Book Value

Annual Sales: $1.32B
Cash Flow: $-1.29B
Price / Cash Flow: 0
Annual Sales: $14.11
Price / Book: 2.98

Profitability

EPS (TTM): -1.11000
Net Income (TTM): $-396.9M
Gross Margin: $1.06B
Return on Equity: -6.53%
Return on Assets: -1.86%

The Carlyle Group Earnings Forecast

Key The Carlyle Group Financial Ratios

  • The Gross Profit Margin over the past 10 years for CG is 58.85%.
  • The Selling, General & Administrative Expenses for CG have been equal to 49.24% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 211.85% of Operating Income.
  • The Net Earning history of CG is -45.94% of Total Revenues.
  • Per Share Earnings over the last 15 years have been positive in 6 years.

The Carlyle Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Capital Markets
Sector: Financials
Current Symbol: CG
CUSIP: 14309L
Website: carlyle.com

Debt

Debt-to-Equity Ratio: 2.1
Current Ratio: 13.61
Quick Ratio: 13.61

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 9.63

CG Technical Analysis vs Fundamental Analysis

Buy
63
The Carlyle Group (CG) is a Buy

Is The Carlyle Group a Buy or a Sell?

  • The Carlyle Group stock is rated a Buy
    The current The Carlyle Group [CG] share price is $41.99. The Score for CG is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.